Actinium Pharmaceuticals, Inc.(NYSE Amex Equities : ATNM)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.10% | 159.87 | 0.0% | $1295.48m | |
| AMGN | Amgen, Inc. | 2.21% | 255.13 | 1.3% | $694.68m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.90% | 8.03 | 0.7% | $561.33m | |
| NVAX | Novavax, Inc. | 0.37% | 202.09 | 80.0% | $556.50m | |
| ILMN | Illumina, Inc. | 0.98% | 401.96 | 3.5% | $517.94m | |
| GILD | Gilead Sciences, Inc. | 0.72% | 65.77 | 1.0% | $463.29m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.80% | 494.64 | 2.7% | $449.68m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.83% | 221.10 | 1.9% | $383.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.45% | 157.54 | 2.0% | $298.86m | |
| BNTX | BioNTech SE | 6.12% | 140.72 | 0.0% | $266.37m | |
| BIIB | Biogen, Inc. | 1.75% | 270.44 | 1.7% | $264.45m | |
| EXAS | EXACT Sciences Corp. | 2.66% | 130.52 | 18.4% | $192.20m | |
| NBIX | Neurocrine Biosciences, Inc. | -0.05% | 95.00 | 4.9% | $177.73m | |
| CRSP | CRISPR Therapeutics AG | 0.60% | 123.85 | 0.6% | $174.50m | |
| SGEN | Seagen Inc. | 3.77% | 149.64 | 5.8% | $153.69m |
Company Profile
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2002 and is headquartered in New York, NY.